Category: Commencement

  • reMYND Commences P-l Study of RES19-T for Alzheimer’s Disease

    Shots: The P-l trial will evaluate the safety, tolerability, and PK of ReS19-T for the treatment of AD. In preclinical studies, ReS19-T has shown to robustly restore synaptic plasticity with an acute response and improve inflammation and AD pathology over a longer treatment duration reMYND has a broad pipeline of novel programs in development, with […]